PURPOSE: To study the effects of a regioisomeric change on the biological activities of previously reported water soluble, colchicine site binding, microtubule depolymerizing agents. METHODS: Nine pyrrolo[3,2-d]pyrimidines were designed and synthesized. The importance of various substituents was evaluated. Their abilities to cause cellular microtubule depolymerization, inhibit proliferation of MDA-MB-435 tumor cells and inhibit colchicine binding to tubulin were studied. One of the compounds was also evaluated in the National Cancer Institute preclinical 60 cell line panel. RESULTS: Pyrrolo[3,2-d]pyrimidine analogs were more potent than their pyrrolo[2,3-d]pyrimidine regioisomers. We identified compounds with submicromolar potency against cellular proliferation. The structure-activity relationship study gave insight into substituents that were crucial for activity and those that improved activity. The compound tested in the NCI 60 cell line is a 2-digit nanomolar (GI(50)) inhibitor of 8 tumor cell lines. CONCLUSION: We have identified substituted pyrrolo[3,2-d]pyrimidines that are water-soluble colchicine site microtubule depolymerizing agents. These compounds serve as leads for further optimization.
PURPOSE: To study the effects of a regioisomericchange on the biological activities of previously reported water soluble, colchicine site binding, microtubule depolymerizing agents. METHODS:Nine pyrrolo[3,2-d]pyrimidines were designed and synthesized. The importance of various substituents was evaluated. Their abilities to cause cellular microtubule depolymerization, inhibit proliferation of MDA-MB-435tumorcells and inhibit colchicine binding to tubulin were studied. One of the compounds was also evaluated in the National Cancer Institute preclinical 60 cell line panel. RESULTS:Pyrrolo[3,2-d]pyrimidine analogs were more potent than their pyrrolo[2,3-d]pyrimidine regioisomers. We identified compounds with submicromolar potency against cellular proliferation. The structure-activity relationship study gave insight into substituents that were crucial for activity and those that improved activity. The compound tested in the NCI 60cell line is a 2-digit nanomolar (GI(50)) inhibitor of 8 tumorcell lines. CONCLUSION: We have identified substituted pyrrolo[3,2-d]pyrimidines that are water-soluble colchicine site microtubule depolymerizing agents. These compounds serve as leads for further optimization.
Authors: Aleem Gangjee; Ying Zhao; Lu Lin; Sudhir Raghavan; Elizabeth G Roberts; April L Risinger; Ernest Hamel; Susan L Mooberry Journal: J Med Chem Date: 2010-10-25 Impact factor: 7.446
Authors: P Skehan; R Storeng; D Scudiero; A Monks; J McMahon; D Vistica; J T Warren; H Bokesch; S Kenney; M R Boyd Journal: J Natl Cancer Inst Date: 1990-07-04 Impact factor: 13.506
Authors: Aleem Gangjee; Roheeth Kumar Pavana; Michael A Ihnat; Jessica E Thorpe; Bryan C Disch; Anja Bastian; Lora C Bailey-Downs; Ernest Hamel; Rouli Bai Journal: ACS Med Chem Lett Date: 2014-02-27 Impact factor: 4.345
Authors: Roheeth Kumar Pavana; Khushbu Shah; Taylor Gentile; Nicholas F Dybdal-Hargreaves; April L Risinger; Susan L Mooberry; Ernest Hamel; Aleem Gangjee Journal: Bioorg Med Chem Date: 2018-09-21 Impact factor: 3.641
Authors: Cristina C Rohena; April L Risinger; Ravi Kumar Vyas Devambatla; Nicholas F Dybdal-Hargreaves; Roma Kaul; Shruti Choudhary; Aleem Gangjee; Susan L Mooberry Journal: Molecules Date: 2016-12-02 Impact factor: 4.411